Role of cytogenetic profiles as prognostic factors for complete remission after induction phase in acute myeloblastic leukemia
Background Risk stratification for acute myeloid leukemia (AML) in children is a must in treatment strategy. This stratification is based on cytogenetic profiles, which are needed to determine proper management to gain better outcomes and reduce side effects of treatment. There is no such risk strat...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Indonesian Pediatric Society Publishing House
2021-11-01
|
| Series: | Paediatrica Indonesiana |
| Subjects: | |
| Online Access: | https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2816 |
| _version_ | 1818346708339261440 |
|---|---|
| author | Hikari Ambara Sjakti Gatot Djajadiman Pustika Amalia Wahidiyat Agus Kosasih Iswari Setianingsih |
| author_facet | Hikari Ambara Sjakti Gatot Djajadiman Pustika Amalia Wahidiyat Agus Kosasih Iswari Setianingsih |
| author_sort | Hikari Ambara Sjakti |
| collection | DOAJ |
| description | Background Risk stratification for acute myeloid leukemia (AML) in children is a must in treatment strategy. This stratification is based on cytogenetic profiles, which are needed to determine proper management to gain better outcomes and reduce side effects of treatment. There is no such risk stratification available in Indonesia until now.
Objective To evaluate the association between cytogenetic profiles of t(8,21) and inv(16) mutations with the complete response to induction phase of chemotherapy in pediatric AML.
Methods A prospective study was conducted between year 2018 and 2020, involving children with AML from 4 pediatric oncology centers in Jakarta. Subjects were evaluated for cytogenetic profiles, especially t(8,21) and inv(16), as the favorable predictors for AML. Bone marrow remission was evaluated after 2 cycles of induction phase. The results were evaluated for remission rate and survival analysis.
Results Karyotype data of 18 subjects were obtained. Translocation t(8;21) detected in 1 subject, and inv(16) mutation in 4 subjects. These two variables had no significant correlation with complete remission after induction phase. Nevertheless, favorable group had more tendencies to achieved remission than unfavorable group. Complete remission achieved in 61% subjects, 90% of theme had a relapse period with an average time 43 weeks. The relapse period in favorable group was shoter than in unfavorable group (34 weeks and 44 weeks, respectively).
Conclusions This study shows that cytogenetic profiles of t(8;21) and inv(16) mutation can not be used as prognostic factors for complete remission after induction phase of chemotherapy in pediatric AML. |
| first_indexed | 2024-12-13T17:22:34Z |
| format | Article |
| id | doaj.art-78f6bdb03031407eba1192944203fd82 |
| institution | Directory Open Access Journal |
| issn | 0030-9311 2338-476X |
| language | English |
| last_indexed | 2024-12-13T17:22:34Z |
| publishDate | 2021-11-01 |
| publisher | Indonesian Pediatric Society Publishing House |
| record_format | Article |
| series | Paediatrica Indonesiana |
| spelling | doaj.art-78f6bdb03031407eba1192944203fd822022-12-21T23:37:16ZengIndonesian Pediatric Society Publishing HousePaediatrica Indonesiana0030-93112338-476X2021-11-01616343910.14238/pi61.6.2021.343-92816Role of cytogenetic profiles as prognostic factors for complete remission after induction phase in acute myeloblastic leukemiaHikari Ambara Sjakti0Gatot Djajadiman1Pustika Amalia Wahidiyat2Agus Kosasih3Iswari Setianingsih4epartment of Pediatric Hematology-Oncology, Cipto Mangunkusumo Hospital, Jakarta, Indonesiaepartment of Pediatric Hematology-Oncology, Cipto Mangunkusumo Hospital, Jakarta, Indonesiaepartment of Pediatric Hematology-Oncology, Cipto Mangunkusumo Hospital, Jakarta, IndonesiaDharmais Cancer Center Hospital, Jakarta, IndonesiaEijkman Institute for Molecular Biology, Jakarta, IndonesiaBackground Risk stratification for acute myeloid leukemia (AML) in children is a must in treatment strategy. This stratification is based on cytogenetic profiles, which are needed to determine proper management to gain better outcomes and reduce side effects of treatment. There is no such risk stratification available in Indonesia until now. Objective To evaluate the association between cytogenetic profiles of t(8,21) and inv(16) mutations with the complete response to induction phase of chemotherapy in pediatric AML. Methods A prospective study was conducted between year 2018 and 2020, involving children with AML from 4 pediatric oncology centers in Jakarta. Subjects were evaluated for cytogenetic profiles, especially t(8,21) and inv(16), as the favorable predictors for AML. Bone marrow remission was evaluated after 2 cycles of induction phase. The results were evaluated for remission rate and survival analysis. Results Karyotype data of 18 subjects were obtained. Translocation t(8;21) detected in 1 subject, and inv(16) mutation in 4 subjects. These two variables had no significant correlation with complete remission after induction phase. Nevertheless, favorable group had more tendencies to achieved remission than unfavorable group. Complete remission achieved in 61% subjects, 90% of theme had a relapse period with an average time 43 weeks. The relapse period in favorable group was shoter than in unfavorable group (34 weeks and 44 weeks, respectively). Conclusions This study shows that cytogenetic profiles of t(8;21) and inv(16) mutation can not be used as prognostic factors for complete remission after induction phase of chemotherapy in pediatric AML.https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2816t(8;21)inv(16)acute myeloid leukemiaprognosticcytogenic |
| spellingShingle | Hikari Ambara Sjakti Gatot Djajadiman Pustika Amalia Wahidiyat Agus Kosasih Iswari Setianingsih Role of cytogenetic profiles as prognostic factors for complete remission after induction phase in acute myeloblastic leukemia Paediatrica Indonesiana t(8;21) inv(16) acute myeloid leukemia prognostic cytogenic |
| title | Role of cytogenetic profiles as prognostic factors for complete remission after induction phase in acute myeloblastic leukemia |
| title_full | Role of cytogenetic profiles as prognostic factors for complete remission after induction phase in acute myeloblastic leukemia |
| title_fullStr | Role of cytogenetic profiles as prognostic factors for complete remission after induction phase in acute myeloblastic leukemia |
| title_full_unstemmed | Role of cytogenetic profiles as prognostic factors for complete remission after induction phase in acute myeloblastic leukemia |
| title_short | Role of cytogenetic profiles as prognostic factors for complete remission after induction phase in acute myeloblastic leukemia |
| title_sort | role of cytogenetic profiles as prognostic factors for complete remission after induction phase in acute myeloblastic leukemia |
| topic | t(8;21) inv(16) acute myeloid leukemia prognostic cytogenic |
| url | https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/2816 |
| work_keys_str_mv | AT hikariambarasjakti roleofcytogeneticprofilesasprognosticfactorsforcompleteremissionafterinductionphaseinacutemyeloblasticleukemia AT gatotdjajadiman roleofcytogeneticprofilesasprognosticfactorsforcompleteremissionafterinductionphaseinacutemyeloblasticleukemia AT pustikaamaliawahidiyat roleofcytogeneticprofilesasprognosticfactorsforcompleteremissionafterinductionphaseinacutemyeloblasticleukemia AT aguskosasih roleofcytogeneticprofilesasprognosticfactorsforcompleteremissionafterinductionphaseinacutemyeloblasticleukemia AT iswarisetianingsih roleofcytogeneticprofilesasprognosticfactorsforcompleteremissionafterinductionphaseinacutemyeloblasticleukemia |